Goldman SACHS GROUP Inc., Insider at Attovia Therapeutics, Inc. (ATTO), bought 585,000 shares at $21.00 ($10.3M) on 2026-08-05, disclosed to the SEC on 2026-08-13.
Goldman Sachs Group Inc. executed a rare reversal buy of 85,000 shares worth $1.79M at $21.00, signaling confidence in the stock's recent decline. This marks the largest insider purchase in the company's history and follows a cluster of four insider buys in the past 30 days.
The stock has dropped 7.1% over the last five days to $19.18, trading 15.69% below its 52-week high of $22.75.
The 4 insider buys in the last 30 days represent a significant cluster of insider support; track this momentum as a potential catalyst for a rebound.
The stock is currently trading 15.69% below its 52-week high, indicating the recent insider purchase comes at a discount to the stock's recent peak.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.00 | 85,000 | $1.8M | 17.4% |
| 2 | $17.00 | 500,000 | $8.5M | 82.6% |
| Total | $17.58 avg | 585,000 | $10.3M | 100% |
| Filing → |
| QVCGP | BUY | 2026-04-22 | $6K | — | Filing → |
| QVCGP | SELL | 2026-04-22 | $5K | — | Filing → |
| SG | BUY | 2026-04-09 | $3.4M | — | Filing → |